Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate and dexmedetomidine for axillary block duration
IRCT2017041920258N38Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate and dexmedetomidine in Forearm Fracture and hand fracture (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Duration of sensory block and Duration of motor block. Started Mar 2017; status: completed.
02
Drugs
magnesium sulfatedexmedetomidine
03
Conditions
Forearm Fracturehand fracture
Beyond the preview
Go deeper on IRCT2017041920258N38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017041920258N38.